Suchergebnisse

[EN] The conformational mobility in poly(ethyl methacrylate-co-hydrxyethyl acrylate) co-polymers was studied by dielectric relaxation spectroscopy, thermally stimulated depolarization currents and dynamic-mechanical experiments. The relaxation strength and the shape of the dielectric relaxation spectra of the homopolymer and co-polymer networks were analyzed using the Havriliak-Negami equation. The dependence of the relaxation strength on co-polymer composition and temperature was analyzed taking into account the merging of the main and the secondary relaxation processes. The shape of the epsilon" versus frequency plots led to the conclusion that the distribution of relaxation times was broader in the co-polymers with intermediate composition than in the homopolymers, a feature that can be explained by the inhomogeneity produced at molecular scale by the sequence distribution of the monomeric units along the chain. Master curves were built both for the elastic modulus and the mechanical loss tangent, and the temperature dependence of the relaxation times was deduced from the shift factors. The fit to the Vogel equation permitted the calculation of the strength parameter, which is higher in the co-polymers that the simple average of the values of the homopolymers, a feature that can be related to the broadness of the distribution of relaxation times. ; The authors are grateful for the support given by the Spanish Science and Technology Ministry through the MAT2003-05391-C03-01 project and by the Valencian Regional Government (Generalitat Valenciana) through the GRUPOS03/018 project. We would like to thank the R + D + i Linguistic Assistance Office at the Universidad Polite´cnica de Valencia for their help in revising this paper ; Gómez-Tejedor, JA.; Rodríguez Acosta, T.; Gómez Ribelles, JL.; Polizos, G.; Pissis, P. (2007). Poly(ethyl methacrylate-co-hydroxyethyl acrylate) random co-polymers: Dielectric and dynamic-mechanical characterization. Journal of Non-Crystalline Solids. 353(3):276-285. ...

When we ask people what they value most, health is usually top of the list. While effective care is available for many chronic diseases, the fact remains that for the patient, the tax payer and the whole of society: prevention is better than cure. Diabetes and its complications are a serious threat to the survival and well-being of an increasing number of people. It is predicted that one in ten Europeans aged 20-79 will have developed diabetes by 2030. Once a disease of old age, diabetes is now common among adults of all ages and is beginning to affect adolescents and even children. Diabetes accounts for up to 18 % of total healthcare expenditure in Europe. The good news is that diabetes is preventable. Compelling evidence shows that the onset of diabetes can be prevented or delayed greatly in individuals at high risk (people with impaired glucose regulation). Clinical research has shown a reduction in risk of developing diabetes of over 50 % following relatively modest changes in lifestyle that include adopting a healthy diet, increasing physical activity, and maintaining a healthy body weight. These results have since been reproduced in real-world prevention programmes. Even a delay of a few years in the progression to diabetes is expected to reduce diabetes-related complications, such as heart, kidney and eye disease and, consequently, to reduce the cost to society. A comprehensive approach to diabetes prevention should combine population based primary prevention with programmes targeted at those who are at high risk. This approach should take account of the local circumstances and diversity within modern society (e.g. social inequalities). The challenge goes beyond the healthcare system. We need to encourage collaboration across many different sectors: education providers, non-governmental organisations, the food industry, the media, urban planners and politicians all have a very important role to play. Small changes in lifestyle will bring big changes in health. Through joint efforts, more people will be reached. The time to act is now.

The prevalence and socioeconomic burden of type 2 diabetes (T2DM) and associated co-morbidities are rising worldwide.This guideline provides evidence-based recommendations for preventing T2DM.A European multidisciplinary consortium systematically reviewed the evidence on the effectiveness of screening and interventions for T2DM prevention using SIGN criteria.Obesity and sedentary lifestyle are the main modifiable risk factors. Age and ethnicity are non-modifiable risk factors. Case-finding should follow a step-wise procedure using risk questionnaires and oral glucose tolerance testing. Persons with impaired glucose tolerance and/or fasting glucose are at high-risk and should be prioritized for intensive intervention. Interventions supporting lifestyle changes delay the onset of T2DM in high-risk adults (number-needed-to-treat: 6.4 over 1.8-4.6 years). These should be supported by inter-sectoral strategies that create health promoting environments. Sustained body weight reduction by>or= 5 % lowers risk. Currently metformin, acarbose and orlistat can be considered as second-line prevention options. The population approach should use organized measures to raise awareness and change lifestyle with specific approaches for adolescents, minorities and disadvantaged people. Interventions promoting lifestyle changes are more effective if they target both diet and physical activity, mobilize social support, involve the planned use of established behaviour change techniques, and provide frequent contacts. Cost-effectiveness analysis should take a societal perspective.Prevention using lifestyle modifications in high-risk individuals is cost-effective and should be embedded in evaluated models of care. Effective prevention plans are predicated upon sustained government initiatives comprising advocacy, community support, fiscal and legislative changes, private sector engagement and continuous media communication.